SARS-CoV-2 vaccines: current situation and prospect
Author:
Affiliation:

Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    The pandemic of coronavirus disease 2019 (COVID-19) seriously threatens human health and development. In response to this global public health event, SARS-CoV-2 vaccine with different techniques has been put into emergency use. This paper introduces the technique of SARS-CoV-2 vaccine, and elaborates the efficacy of COVID-19 vaccine against various mutant strains and its use in high-risk population. It is found that the effectiveness of the existing vaccines to mutant strains has declined to some extent, which suggests that the impact of mutant strains should be paid attention to. The existing vaccines lack sufficient clinical data for the elderly, pregnant women and other high-risk groups, so it is necessary to carry out research on vaccination for high-risk groups as soon as possible.

    Reference
    Related
Get Citation

杨天涵,张晓燕,徐建青.新型冠状病毒疫苗: 现状与展望[J].中国感染控制杂志英文版,2021,(7):673-680. DOI:10.12138/j. issn.1671-9638.20211194.
Tian-han YANG, Xiao-yan ZHANG, Jian-qing XU. SARS-CoV-2 vaccines: current situation and prospect[J]. Chin J Infect Control, 2021,(7):673-680. DOI:10.12138/j. issn.1671-9638.20211194.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 01,2021
  • Revised:
  • Adopted:
  • Online: August 04,2021
  • Published: